Your browser doesn't support javascript.
loading
Research Review: Recommendations for reporting on treatment trials for child and adolescent anxiety disorders - an international consensus statement.
Creswell, Cathy; Nauta, Maaike H; Hudson, Jennifer L; March, Sonja; Reardon, Tessa; Arendt, Kristian; Bodden, Denise; Cobham, Vanessa E; Donovan, Caroline; Halldorsson, Brynjar; In-Albon, Tina; Ishikawa, Shin-Ichi; Johnsen, Daniel Bach; Jolstedt, Maral; de Jong, Rachel; Kreuze, Leonie; Mobach, Lynn; Rapee, Ronald M; Spence, Susan H; Thastum, Mikael; Utens, Elisabeth; Vigerland, Sarah; Wergeland, Gro Janne; Essau, Cecilia A; Albano, Anne Marie; Chu, Brian; Khanna, Muniya; Silverman, Wendy K; Kendall, Philip C.
Afiliación
  • Creswell C; Department of Experimental Psychology, University of Oxford, Oxford, UK.
  • Nauta MH; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Hudson JL; Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.
  • March S; Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, NSW, Australia.
  • Reardon T; School of Psychology and Counselling, University of Southern Queensland, Springfield, QLD, Australia.
  • Arendt K; Department of Experimental Psychology, University of Oxford, Oxford, UK.
  • Bodden D; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Cobham VE; Cognitive Therapy Centre Aarhus, Aarhus, Denmark.
  • Donovan C; Department of Child and Adolescent Studies, Utrecht University, Utrecht, The Netherlands.
  • Halldorsson B; Children's Health QLD Child and Youth Mental Health Service, Brisbane, QLD, Australia.
  • In-Albon T; School of Psychology, The University of Queensland, Brisbane, QLD, Australia.
  • Ishikawa SI; School of Applied Psychology, Griffith University, Brisbane, QLD, Australia.
  • Johnsen DB; Department of Experimental Psychology, University of Oxford, Oxford, UK.
  • Jolstedt M; Department of Psychiatry, University of Oxford, Oxford, UK.
  • de Jong R; Department of Psychology, Reykjavik University, Reykjavik, Iceland.
  • Kreuze L; Clinical Child and Adolescent Psychology and Psychotherapy Unit, University of Koblenz and Landau, Landau, Germany.
  • Mobach L; Faculty of Psychology, Doshisha University, Kyoto, Japan.
  • Rapee RM; Cognitive Therapy Centre Aarhus, Aarhus, Denmark.
  • Spence SH; Department of Clinical Neuroscience, Centre for Psychiatry Research, Karolinska Institutet, Stockholm, Sweden.
  • Thastum M; Stockholm Health Care Services, Stockholm County Council, Stockholm, Sweden.
  • Utens E; Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.
  • Vigerland S; Department of Clinical Psychology and Experimental Psychopathology, University of Groningen, Groningen, The Netherlands.
  • Wergeland GJ; Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, NSW, Australia.
  • Essau CA; Behavioural Science Institute, Radboud University, Nijmegen, The Netherlands.
  • Albano AM; Department of Psychology, Centre for Emotional Health, Macquarie University, Sydney, NSW, Australia.
  • Chu B; School of Applied Psychology, Griffith University, Brisbane, QLD, Australia.
  • Khanna M; Australian Institute for Suicide Research and Prevention, Griffith University, Brisbane, QLD, Australia.
  • Silverman WK; Cognitive Therapy Centre Aarhus, Aarhus, Denmark.
  • Kendall PC; Research Institute of Child Development and Education, University of Amsterdam / The Bascule / Amsterdam UMC, Amsterdam, The Netherlands.
J Child Psychol Psychiatry ; 62(3): 255-269, 2021 03.
Article en En | MEDLINE | ID: mdl-32683742
BACKGROUND: Anxiety disorders in children and young people are common and bring significant personal and societal costs. Over the last two decades, there has been a substantial increase in research evaluating psychological and pharmacological treatments for anxiety disorders in children and young people and exciting and novel research has continued as the field strives to improve efficacy and effectiveness, and accessibility of interventions. This increase in research brings potential to draw together data across studies to compare treatment approaches and advance understanding of what works, how, and for whom. There are challenges to these efforts due largely to variation in studies' outcome measures and variation in the way study characteristics are reported, making it difficult to compare and/or combine studies, and this is likely to lead to faulty conclusions. Studies particularly vary in their reliance on child, parent, and/or assessor-based ratings across a range of outcomes, including remission of anxiety diagnosis, symptom reduction, and other domains of functioning (e.g., family relationships, peer relationships). METHODS: To address these challenges, we convened a series of international activities that brought together the views of key stakeholders (i.e., researchers, mental health professionals, young people, parents/caregivers) to develop recommendations for outcome measurement to be used in treatment trials for anxiety disorders in children and young people. RESULTS AND CONCLUSIONS: This article reports the results of these activities and offers recommendations for selection and reporting of outcome measures to (a) guide future research and (b) improve communication of what has been measured and reported. We offer these recommendations to promote international consistency in trial reporting and to enable the field to take full advantage of the great opportunities that come from data sharing going forward.
Asunto(s)
Palabras clave

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastornos de Ansiedad / Familia Tipo de estudio: Guideline Idioma: En Revista: J Child Psychol Psychiatry Año: 2021 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Trastornos de Ansiedad / Familia Tipo de estudio: Guideline Idioma: En Revista: J Child Psychol Psychiatry Año: 2021 Tipo del documento: Article